Order results by:
Issue | Title | |
Vol 12, No 4 (2019) | Optimization of drug supply for patients with malignant neoplasms in a region of the Russian Federation | Abstract similar documents |
A. V. Nikitina, F. V. Gorkavenko, Y. S. Saybel, M. V. Avxentyeva, M. S. Sura, D. V. Fedyaev | ||
"... of the same drugs replaced with generics or biosimilars for a 5 year period. Results. By gradually replacing ..." | ||
Vol 12, No 2 (2019) | Dynamics of prices and consumption of anticancer drugs in Russia after their generics and biosimilars became available | Abstract similar documents |
F. V. Gorkavenko, A. V. Nikitina, E. S. Saibel’, M. V. Avksent’eva, M. V. Sura, D. V. Fedyaev | ||
"... names (INN) of anticancer drugs, whose generics or biosimilars entered the Russian pharmaceutical market ..." | ||
Vol 10, No 4 (2017) | INTERNATIONAL APPROACHES TO THE GOVERNMENT PRICE CONTROL OVER GENERICS AND BIOSIMILARS: A REVIEW | Abstract similar documents |
D. G. Tolkacheva, A. V. Torgov, A. S. Margazova | ||
"... the reference group of drugs. However, today’s control of biosimilar pricing in Europe is just building up ..." | ||
Vol 10, No 4 (2017) | INTERNATIONAL APPROACHES TO THE GOVERNMENT PRICE CONTROL OVER GENERICS AND BIOSIMILARS: A REVIEW | Abstract similar documents |
D. G. Tolkacheva, A. V. Torgov, A. S. Margazova | ||
"... the reference group of drugs. However, today’s control of biosimilar pricing in Europe is just building up ..." | ||
Vol 11, No 1 (2018) | Options to optimize the access to biosimilars: analysis and solutions | Abstract similar documents |
O. V. Kirsanova, V. V. Omelyanovsky | ||
"... products – biosimilars – in the Russian Federation and elsewhere (USA, EU) are addressed. We propose ..." | ||
Vol 13, No 2 (2020) | Review of calculation methods, procedures for registration and re-registration of producer prices of medicines in the countries of the Eurasian Economic Union | Abstract similar documents |
A. A. Leshkevich, D. S. Yurochkin, Z. M. Golant, I. A. Narkevich | ||
"... of pharmaceutical drugs in the Eurasian Economic Community counties (EAEC). Materials and Methods. The comparison ..." | ||
Vol 11, No 3 (2018) | What is the role of antineoplastic drug safety in reimbursement decision making? | Abstract similar documents |
A. S. Kolbin, A. A. Kurylev | ||
"... Rationale. From 2014 to 2017, the portion of antineoplastic drugs dossiers submitted ..." | ||
Vol 9, No 1 (2016) | MATHEMATICAL MODEL OF REIMBURSEMENT DECISION MAKING IN RUSSIA. RESULTS OF VIM LIST FOR 2016 | Abstract similar documents |
A. S. Kolbin, A. V. Prasolov, E. A. Maksimkina, Yu. E. Balykina, Z. M. Golant, Yu. S. Polushin, A. A. Kurylev, I. A. Vilyum | ||
"... Background: In 2014 we firstly analyzed the formalized system (points and expert opinions) of drug ..." | ||
Vol 7, No 1 (2014) | PHARMACOEPIDEMIOLOGY: FROM THEORY TO PRACTICE | Abstract similar documents |
S. A. Rachina, R. S. Kozlov, Yu. A. Belkova | ||
"... the use of and the effects of drugs in the whole population or in large groups of people in order ..." | ||
Vol 9, No 3 (2016) | DRUGS PROVIDED TO BREAST CANCER PATIENTS WITHIN THE STATE PROGRAMS OF DRUG SUPPLY | Abstract similar documents |
M. V. Avxentyeva, V. I. Bogin, E. V. Derkach, V. V. Omelyanovskiy, M. B. Stenina, A. V. Tarakanov, M. Yu. Frolov | ||
"... cancer in various regions of the Russian Federation in the framework of state programs of drug provision ..." | ||
Vol 10, No 1 (2017) | RESTRICTIVE LISTS OF DRUGS: REGULATIONS, FUNCTIONS, SOURCES OF FINANCE, AND GUIDELINES FOR CREATION | Abstract similar documents |
M. V. Sura | ||
"... and sources of finance pertaining to the restrictive lists of drugs, which play a substantial role in the drug ..." | ||
Vol 8, No 2 (2015) | PRINCIPLES OF IMPORT SUBSTITUTION REGARDING DRUGS | Abstract similar documents |
Alana Viktorovna Dzaneva, Vitalii Vladimirovich Omel'yanovskii, Saniyat Aleksandrovna Kagermazova | ||
"... This articles is devoted to major principles of import substitution regarding drugs within ..." | ||
Vol 11, No 1 (2018) | Pharmacoeconomic assessment of antipsychotic treatment in outpatients with schizophrenia | Abstract similar documents |
I. A. Vilyum, B. V. Andreev, M. A. Proskurin, Yu. E. Balykina | ||
"... disappears, and the CA drugs have a lower CER instead. For the «number of hospitalization-free days per year ..." | ||
Vol 11, No 2 (2018) | Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia | Abstract similar documents |
I. A. Vilyum, B. V. Andreev, M. A. Proskurin, Yu. E. Balykina | ||
"... was increased to 24 months, this economic advantage of AA diminished, and the kA drugs had a lower CeR instead ..." | ||
Vol 7, No 1 (2014) | EVALUATION OF SAFETY OF DRUG THERAPY IN CLINICAL PRACTICE | Abstract similar documents |
M. N. Kostyleva, Yu. B. Belousov, A. N. Gratsianskaya, S. S. Postnikov | ||
"... ), account and analysis of the adverse reactions of drugs in post-marketing period are described. The off ..." | ||
Vol 5, No 1 (2012) | DYNAMICS OF PREFERENTIAL MAINTENANCE OF CITIZENS WITH ANTIHYPERTENSIVE DRUGS AT THE EXPENSE OF THE REGIONAL BUDGET | Abstract similar documents |
I. I. Lavrentyeva, A. I. Khokhlov, I. N. Kagramanyan, T. A. Gorokhova | ||
"... released antihypertensive drugs that are caused by decrease in average costof one prescription. ..." | ||
Vol 12, No 4 (2019) | Clinical and economic analysis of drug costs in a general hospital in 2014-2018 | Abstract similar documents |
A. T. Burbello, A. S. Fedorenko, E. L. Latariya, M. V. Pokladova, K. A. Zagorodnikova | ||
"... Objectives. To study the structure of drug purchases by a general hospital considering the names ..." | ||
Vol 9, No 2 (2016) | MANAGEMENT ASPECT OF THE PROBLEM OF NARCOTIC DRUGS USE | Abstract similar documents |
S. Yu. Soboleva, A. V. Sobolev, I. A. Kaminskaya | ||
"... The use of narcotic drugs in healthcare system nowadays is characterized by lawful aspects ..." | ||
Vol 10, No 3 (2017) | The strategies of drug supply for patients with chronic hepatitis C | Abstract similar documents |
E. V. Kornilova, A. D. Ermolaeva, M. G. Rusanova, D. A. Andreev, M. V. Davydovskaya, T. N. Ermolaeva, A. g Pokatilo, K. I. Polyakova, V. A. Dubovtseva, K. А. Kokushkin, A. V. Devyatkin | ||
"... The report reviews the options of drug supply for patients with chronic hepatitis C in the Russian ..." | ||
Vol 10, No 4 (2017) | THE INTERNATIONAL PRACTICE OF DRUG SUPPLY IN THE OUTPATIENT SEGMENT | Abstract similar documents |
D. V. Lukyantseva, L. S. Mel’nikova, A. P. Tatarinov | ||
"... The paper examines the international experience of drug supply and the risks faced by countries ..." | ||
Vol 11, No 1 (2018) | Modeling microbial drug-resistance: from mathematics to pharmacoeconomics | Abstract similar documents |
Yu. M. Gomon, M. A. Arepyeva, Yu. E. Balykina, A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, S. V. Sidorenko | ||
"... optimal algorithm for using antimicrobial agents (AMA) that would minimize the evolving drug-resistance ..." | ||
Vol 7, No 4 (2014) | ROAD MAP FOR DEVELOPMENT OF PRICE REGULATION SYSTEM AND SYSTEM OF DRUG SUPPLY AT THE EXPENSE OF RUSSIAN FEDERATION HEALTHCARE SYSTEM FUNDS | Abstract similar documents |
M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentieva | ||
"... study goal is to prepare a road map for development of price regulation system and system of drug ..." | ||
Vol 13, No 2 (2020) | Improvements to the formation of lists of drugs for medical use: analysis of changes in the Government Decree no. 871 | Abstract similar documents |
V. V. Omelyanovskiy, E. A. Maksimkina, O. I. Ivakhnenko, M. V. Avxentyeva, M. V. Sura, G. R. Khachatryan | ||
"... development of approaches for complex drug assessment in Russia, also criteria for its evaluation were under ..." | ||
Vol 7, No 2 (2014) | ANALYSIS OF DRUG PRODUCTS ASSORTMENT ACQUIRABLE BY HEALTHCARE ORGANIZATIONS FOR MEDICAL TREATMENT IN HOSPITAL SETTINGS WAS CONDUCTED | Abstract similar documents |
M. G. Malaev | ||
"... analysis of drug products assortment acquirable by healthcare organizations for medical treatment ..." | ||
Vol 7, No 3 (2014) | ASSESSMENT OF NECESSARY FINANCIAL EXPENSES ON THE DRUG SUPPLY OF THE PATIENTS WITH ORPHAN DISEASES IN THE RUSSIAN FEDERATION | Abstract similar documents |
M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentyeva | ||
"... the article presents the results of cost calculation on the drug supply of the patients ..." | ||
Vol 7, No 4 (2014) | АNALYSIS OF PSYCHOTROPIC DRUG CONSUPTION FOR SCHIZOPHRENIA TREATMENT IN DIFFERENT TYPE HOSPITALS | Abstract similar documents |
P. S. Nosova, O. V. Reshetko | ||
"... the goal of our research was to carry out an analysis of psychotropic drug utilization used ..." | ||
Vol 7, No 4 (2014) | APPLICATION OF MULTIPLE-CRITERIA ANALYSIS FOR OPTIMIZATION OF FINANCING OF RARE DISEASES | Abstract similar documents |
V. V. Omelyanovskiy, V. K. Fedyaeva, O. Yu. Rebrova | ||
"... financing of rare disease drugs remains a serious problem for both foreign countries and our ..." | ||
Vol 8, No 2 (2015) | REASONS FOR DIFFICULTY OF THE PHARMACOECONOMIC ANALYSIS FOR ORPHAN DRUGS. WAYS FOR SOLUTIONS | Abstract similar documents |
Andrey Vladislavovich Pavlysh, Aleksei Sergeevich Kolbin, Roman Andreevich Gapeshin, Stanislav Mikhailovich Malyshev | ||
"... Orphan drugs are used for treatment of rare life-threatening diseases. There is no universal ..." | ||
Vol 9, No 2 (2016) | PHARMACOECONOMIC ANALYSIS OF VESOMNI (SOLIFENACIN AND CONTROLLED RELEASE TAMSULOSIN) TREATMENT OF STORAGE SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA | Abstract similar documents |
N. A. Avxentyev, M. Yu. Frolov | ||
"... The aim of the current study is pharmacoeconomic evaluation of using combined drug Vesomni ..." | ||
Vol 9, No 2 (2016) | METASTATIC COLORECTAL TREATMENT COSTS OF USING TARGETED DRUGS IN SECOND AND FURTHER LINES THERAPY | Abstract similar documents |
N. A. Avxentyev, E. V. Derkach, E. A. Pyadushkina, M. D. Ter-Ovanesov | ||
"... Targeted drugs are recommended for treatment of metastatic colorectal cancer. Second and further ..." | ||
Vol 9, No 3 (2016) | CLINICAL AND ECONOMIC EVALUATION OF LACOSAMIDE IN PATIENTS WITH PARTIAL EPILEPSY | Abstract similar documents |
E. A. Pyadushkina, M. Yu. Frolov | ||
"... of the Russian Federation in three scenarios: Lacosamide as concomitant drug to standard therapy in comparison ..." | ||
Vol 11, No 4 (2018) | Treatment of patients with malignant lymphoproliferative diseases in the Russian Federation: analysis of the data from 75 regions | Abstract similar documents |
G. R. Hachatryan, T. S. Teptsova, V. A. Lemeshko, N. Z. Musina | ||
"... . Among the malignant LPDs, the highest costs of drug therapy in 2016 pertained to lymphosarcoma ..." | ||
Vol 12, No 2 (2019) | Health technology assessment and reimbursement of pharmaceuticals in Italy | Abstract similar documents |
F. V. Gorkavenko, V. V. Omelyanovskiy, T. P. Bezdenezhnykh, G. R. Khachatryan | ||
Vol 12, No 3 (2019) | Clinical and economic analysis as an instrument for harmonizing import substitution in the preferential segment of medicinal support | Abstract similar documents |
E. V. Eliseeva , E. S. Maneeva , R. K. Goncharova , A. V. Kropotov | ||
"... the qualitative and quantitative indicators of drug supply. Materials and methods. We used the official ..." | ||
Vol 12, No 4 (2019) | The health technology assessment system in Australia | Abstract similar documents |
V. V. Omelyanovskiy, E. S. Saybel, T. P. Bezdenezhnykh, G. R. Khachatryan | ||
"... by the federal budget. The drug evaluation process includes five stages: a review of general information about ..." | ||
Vol 7, No 4 (2014) | IS RUSSIA READY FOR THE INTRODUCTION OF THE NATIONAL REFERENCE PRICING SYSTEM? | Abstract similar documents |
V. V. Omelyanovskiy | ||
"... the analysis of foreign pricing and drug supply public funding systems (or a so-called drug ..." | ||
Vol 9, No 1 (2016) | PHARMACOECONOMIC EVALUATION OF RUFINAMIDE USE FOR THE LENNOX-GASTAUT SYNDROME TREATMENT | Abstract similar documents |
N. K. Mazina, P. V. Mazin, Yu. V. Kislitsin, E. M. Markova | ||
"... to evaluate the efficacy of the drug in this pathology, a systematic review of publications of the results ..." | ||
Vol 6, No 2 (2013) | PHARMACOECONOMIC MODELING OF ANTIRETROVIRAL DRUGS USE DURING TREATMENT OF HIV INFECTION | Abstract similar documents |
V. A. Chibilyaev, A. Yu. Kulikov, R. I. Yagudina | ||
Vol 6, No 3 (2013) | PHARMACOECONOMIC ANALYSIS OF NEUROPROTECTIVE DRUGS IN THE TREATMENT OF ACUTE DISORDERS OF CEREBRAL CIRCULATION | Abstract similar documents |
A. Yu. Kulikov, I. Yu. Zinchuk | ||
"... Based on meta-analysis dates found, that the effectiveness of neuroprotective drugs and placebo ..." | ||
Vol 10, No 2 (2017) | COSTS OF ANTIRETROVIRAL DRUGS USED IN THE THERAPY OF HIV-INFECTED PATIENTS: A PHARMACOECONOMIC ANALYSIS | Abstract similar documents |
M. B. Kubaeva, Y. Sh. Guchshina | ||
"... of anti-HIV drugs. Material and methods. The study was based on the documented medical histories of HIV ..." | ||
Vol 10, No 3 (2017) | Review of the current approaches to the assessment of the drug innovative potential worldwide | Abstract similar documents |
N. Z. Musina, V. K. Fedyaeva, V. V. Omel’yanovskii, G. R. Khachatryan, K. V. Gerasimova, V. A. Lemeshko, K. P. Konchits | ||
"... A set of criteria for assessing the innovative potential of drugs (therapeutic value) have been ..." | ||
Vol 13, No 3 (2020) | Chemomicrobiomic analysis of glucosamine sulfate, prebiotics and non-steroidal anti-inflammatory drugs | Abstract similar documents |
O. A. Gromova, I. Yu. Torshin, A. V. Naumov, V. A. Maksimov | ||
"... Introduction. The pharmaceutical drugs used in the treatment of osteoarthritis (OA) differ ..." | ||
Vol 12, No 3 (2019) | Pharmacoepidemiological analysis of antimicrobial therapy for burn injury in the hospital settings | Abstract similar documents |
O. V. Zhukova, E. S. Nekaeva, E. S. Khoroshavina, E. A. Kozlova, Yu. A. Dudukina, I. Yu. Arefyev | ||
"... ) analysis was used to evaluate the actual drug consumption based on the defined daily dose; DU90% (Drug ..." | ||
Vol 12, No 2 (2019) | Recent changes in the pharmacovigilance system in the Russian Federation and the EAEU | Abstract similar documents |
G. N. Gildeeva, A. V. Belostotsky | ||
"... ) and risk management plans (RMP) was also carried out. Results. The united EAEU drug market is a complex ..." | ||
Vol 8, No 1 (2015) | PAYMENT OF NEW EXPENSIVE TECHNOLOGIES IN HEALTH CARE ON THE BASIS OF RISKS -SHARING AGREEMENTS: POSSIBILITIES OF APPLICATION IN THE RUSSIAN FEDERATION | Abstract similar documents |
L. S. Melnikova | ||
"... are used in foreign countries at reimbursement of costs for public drug supply. The author estimates ..." | ||
Vol 11, No 2 (2018) | Pharmacoeconomic analysis of treatment with nilotinib as the second line therapy in patients with chronic myeloid leukemia | Abstract similar documents |
N. A. Avxentyev, M. Yu. Frolov, A. S. Makarov | ||
"... are registered in second-line, however only dasatinib is included in the government drug reimbursement program ..." | ||
Vol 13, No 2 (2020) | Affordability of in vivo gene therapy. Problems and potential solutions | Abstract similar documents |
V. V. Omelyanovskiy, N. Z. Musina, V. A. Lemeshko, A. A. Antonov, F. V. Gorkavenko | ||
"... Aim. To review foreign approaches to the evaluation and financing of in vivo gene therapy drugs ..." | ||
Vol 13, No 3 (2020) | Comparative analysis of antipsychotic drug consumption for inpatient schizophrenia treatment: a retrospective study with 5-year follow-up | Abstract similar documents |
L. B. Vaskova, M. V. Tiapkina, E. V. Mikhaylenko | ||
"... of antipsychotic drugs (APD) used for inpatient treatment for schizophrenia. Materials and methods ..." | ||
Vol 5, No 1 (2012) | PHARMACOECONOMIC EVALUATION OF THE PROPHYLAXIS OF POSTSURGICAL INFECTIOUS INFLAMMATORY COMPLICATIONS OF COMBINED ANTIBIOTIC DRUGS AND CORTICOSTEROIDS IN OPHTHALMIC PRACTICE IN RUSSIAN FEDERATION | Abstract similar documents |
V. G. Serpik, R. I. Yagudina | ||
Vol 9, No 3 (2016) | HEALTH ECONOMIC ASSESSMENT OF ANTIRHEUMATIC DRUGS IN PATIENTS WITH REUMATHOID ARTHRITIS PROGRESSED AFTER METOTREXATE | Abstract similar documents |
A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, Yu. E. Balykina | ||
"... Objective. To perform health economic evaluation of several antirheumatic drugs in patients ..." | ||
1 - 50 of 113 Items | 1 2 3 > >> |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)